LY3023703
LY3023703 is an orally active microsomal prostaglandin E synthase-1 (mPGES-1) inhibitor. LY3023703 inhibits the production of PGE2. LY3023703 is applicable to research related to inflammatory diseases and osteoarthritis pain.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1415089-24-5
- Formule: C23H22F5N5O2
- Masse moléculaire:495.45
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
12 nM
Compound: 20
|
Inhibition of mPGES-1 in human A549 cells assessed as PEG2 formation preincubated for 30 mins followed by recombinant human interleukin 1beta addition measured after 18 hrs by LC/MS analysis
Inhibition of mPGES-1 in human A549 cells assessed as PEG2 formation preincubated for 30 mins followed by recombinant human interleukin 1beta addition measured after 18 hrs by LC/MS analysis
|
[PMID: 26791385] |
LY3023703 (Compound 8) potently inhibits human mPGES-1 microsomes, with an IC50 of 0.9 nM[1].
LY3023703 weakly inhibits rat mPGES-1 microsomes, with an IC50 value of 33.9 μM[1].
LY3023703 inhibits the production of PGE2 in IL-1β-stimulated A549 cells with an IC50 of 12 nM, without affecting the production of PGI2[1].
LY3023703 inhibits LPS (HY-D1056)-stimulated PGE2 production in human whole blood, with an IC50 of 12 nM and an IC80 of 69 nM, without affecting the production of TXB2 or PGF2α[1].
LY3023703 inhibits LPS-stimulated PGE2 production in canine whole blood, with an IC50 of 139 nM and an IC80 of 703 nM[1].
LY3023703 (10 μM; 30 min preincubation, 1 min reaction) weakly inhibits microsomal CYP3A4 in a time-dependent manner[1].
LY3023703 inhibits hERG channels with an IC50 of 82.6 μM, compared with an IC80 of 69 nM against HWB PGE2[1].
LY3023703 (Compound 2) potently inhibits mPGES-1-mediated PGE2 production in human whole blood, with an IC50 of 0.012 μM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1415089-24-5
-
Masse moléculaire 495.45
-
Formule C23H22F5N5O2
-
SMILES
O=C(C1=CC(CNC(C(C)C)=O)=CN=C1C(F)F)NC2=NC(C)=C(C3=CC=C(C(F)(F)F)C=C3)N2
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Schiffler MA, et al. Discovery and Characterization of 2-Acylaminoimidazole Microsomal Prostaglandin E Synthase-1 Inhibitors. J Med Chem. 2016;59(1):194-205. [Content Brief]
[2]. Norman BH, et al. Identification and Mitigation of Reactive Metabolites of 2-Aminoimidazole-Containing Microsomal Prostaglandin E Synthase-1 Inhibitors Terminated Due to Clinical Drug-Induced Liver Injury. J Med Chem. 2018;61(5):2041-2051. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
LY3023703 Related Classifications
HY-182647 Related Classifications
Powered by Bioz